Encompass Health Corporation
US ˙ NYSE ˙ US29261A1007

SecurityEHC / Encompass Health Corporation
InstitutionSilvercrest Asset Management Group Llc
Latest Disclosed Ownership301,376 shares
Latest Disclosed Value $ 29,152,221
Silvercrest Asset Management Group Llc reports 12.58% decrease in ownership of EHC / Encompass Health Corporation

On May 15, 2026 - Silvercrest Asset Management Group Llc filed a 13F-HR form disclosing ownership of 301,376 shares of Encompass Health Corporation (US:EHC) valued at $29,152,100 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 344,746 shares of Encompass Health Corporation. This represents a change in shares of -12.58% during the quarter. The current value of the position is $31,092,962 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ENCOMPASS HEALTH CORP COM COM 29261A100 301,376 -43,370 -12.58 29,152 -20.33 0.2106
2026-02-17 2025-12-31 13F ENCOMPASS HEALTH COM 29261A100 344,746 -16,451 -4.55 36,592 -20.24 0.2515
2025-11-14 2025-09-30 13F ENCOMPASS HEALTH CORP COM COM 29261A100 361,197 30,497 9.22 45,879 13.13 0.3036
2025-08-14 2025-06-30 13F ENCOMPASS HEALTH COM 29261A100 330,700 -14,049 -4.08 40,554 16.14 0.2724
2025-05-15 2025-03-31 13F ENCOMPASS HEALTH COM 29261A100 344,749 4,658 1.37 34,916 11.17 0.2499
2025-02-14 2024-12-31 13F ENCOMPASS HEALTH COM 29261A100 340,091 181,693 114.71 31,407 105.18 0.2098
2024-11-14 2024-09-30 13F ENCOMPASS HEALTH CORP COM COM 29261A100 158,398 -1,214 -0.76 15,308 11.79 0.1042
2024-08-15 2024-06-30 13F/A-1 ENCOMPASS HEALTH CORP COM COM 29261A100 159,612 -92,378 -36.66 13,693 -34.20 0.0939
2024-08-14 2024-06-30 13F ENCOMPASS HEALTH CORP COM COM 29261A100 319,224 67,234 27,386 0.0626
2024-05-15 2024-03-31 13F ENCOMPASS HEALTH CORP COM COM 29261A100 251,990 4,258 1.72 20,809 25.90 0.1408
2024-02-14 2023-12-31 13F ENCOMPASS HEALTH CORP COM COM 29261A100 247,732 -10,724 -4.15 16,529 -4.78 0.1169
2023-11-14 2023-09-30 13F ENCOMPASS HEALTH CORP COM COM 29261A100 258,456 -13,416 -4.93 17,358 -5.71 0.1318
2023-08-14 2023-06-30 13F ENCOMPASS HEALTH CORP COM COM 29261A100 271,872 25,851 10.51 18,408 38.31 0.1313
2023-05-15 2023-03-31 13F ENCOMPASS HEALTH CORP COM COM 29261A100 246,021 -5,009 -2.00 13,310 -11.36 0.1011
2023-02-14 2022-12-31 13F ENCOMPASS HEALTH CORP COM COM 29261A100 251,030 -6,143 -2.39 15,014 29.07 0.1154
2022-11-14 2022-09-30 13F ENCOMPASS HEALTH CORP COM COM 29261A100 257,173 594 0.23 11,632 -19.12 0.0957
2022-08-15 2022-06-30 13F ENCOMPASS HEALTH CORP COM COM 29261A100 256,579 2,069 0.81 14,381 -20.54 0.1093
2022-05-16 2022-03-31 13F ENCOMPASS HEALTH CORP COM COM 29261A100 254,510 115,431 83.00 18,098 100.73 0.1175
2022-02-14 2021-12-31 13F ENCOMPASS HEALTH CORP COM COM 29261A100 139,079 1,438 1.04 9,016 -12.71 0.0571
2021-11-15 2021-09-30 13F ENCOMPASS HEALTH CORP COM COM 29261A100 137,641 -6,256 -4.35 10,329 -8.01 0.0696
2021-08-16 2021-06-30 13F ENCOMPASS HEALTH CORP COM COM 29261A100 143,897 -2,138 -1.46 11,228 -6.12 0.0736
2021-05-17 2021-03-31 13F ENCOMPASS HEALTH CORP COM COM 29261A100 146,035 2,424 1.69 11,960 0.72 0.0808
2021-02-16 2020-12-31 13F ENCOMPASS HEALTH CORP COM COM 29261A100 143,611 3,124 2.22 11,875 30.08 0.0867
2020-11-16 2020-09-30 13F ENCOMPASS HEALTH CORP COM COM 29261A100 140,487 4,056 2.97 9,129 8.05 0.0783
2020-08-14 2020-06-30 13F ENCOMPASS HEALTH CORP COM COM 29261A100 136,431 10,908 8.69 8,449 5.13 0.0749
2020-05-15 2020-03-31 13F ENCOMPASS HEALTH CORP COM COM 29261A100 125,523 -598 -0.47 8,037 -8.00 0.0862
2020-02-14 2019-12-31 13F ENCOMPASS HEALTH CORP COM COM 29261A100 126,121 3,379 2.75 8,736 12.46 0.0678
2019-11-14 2019-09-30 13F ENCOMPASS HEALTH CORP COM COM 29261A100 122,742 -22,346 -15.40 7,768 -15.50 0.0641
2019-08-14 2019-06-30 13F ENCOMPASS HEALTH CORP COM COM 29261A100 145,088 19,967 15.96 9,193 25.81 0.0861
2019-05-15 2019-03-31 13F ENCOMPASS HEALTH CORP COM COM 29261A100 125,121 12,792 11.39 7,307 5.44 0.0718
2019-02-14 2018-12-31 13F ENCOMPASS HEALTH CORP COM COM 29261A100 112,329 6,054 5.70 6,930 -16.34 0.0763
2018-11-14 2018-09-30 13F ENCOMPASS HEALTH CORP COM COM 29261A100 106,275 19,225 22.09 8,284 40.53 0.0752
2018-08-14 2018-06-30 13F ENCOMPASS HEALTH CORP COM COM 29261A100 87,050 3,467 4.15 5,895 23.38 0.0552
2018-05-15 2018-03-31 13F ENCOMPASS HEALTH CORP COM COM 29261A100 83,583 83,583 4,778 0.0466
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.